Besides for its utility in Alzheimer’s disease, in vivo PET data provided evidence that [11C]PBB3 was capable of detecting tau aggregates in patients with non-AD dementias as exemplified by CBD as well [12]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.